Method of detecting mild impaired glucose tolerance or insulin secretory defect
Abstract
It is intended to provide a noninvasive method of conveniently detecting mild impaired glucose tolerance and/or insulin hyposecretion at the early stage with the use of an enzyme. Namely, mild impaired glucose tolerance and/or insulin hyposecretion at the early stage are detected by quantifying myoinositol secreted into the urine before loading glucose and after loading glucose for a definite period of time with the use of a reagent and comparing the increase (or the increase ratio) in the myoinositol content thus measured with a characteristic level which has been preliminarily determined in normal subjects.
Claims
exact text as granted — not AI-modified1 - 14 . (canceled)
15 . A method of eliminating glucose in a sample, characterized in that two kinds of kinases are simultaneously used for the reaction of eliminating glucose in the sample.
16 . The method of eliminating glucose according to claim 15 , characterized in that said two kinds of kinases are ATP-hexokinase and an ADP eliminating agent.
17 . The method of eliminating glucose according to claim 16 , wherein the ADP eliminating agent is ADP-hexokinase.
18 - 26 . (canceled)Join the waitlist — get patent alerts
Track US2009042279A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.